Royal Bank of Canada Trims Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)

Royal Bank of Canada reduced its position in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 6.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,304,193 shares of the company’s stock after selling 158,557 shares during the quarter. Royal Bank of Canada owned about 0.07% […]

Related Keywords

Canada ,Daliresp Daxas ,Xigduo ,Duaklir Genuair ,Farxiga Forxiga ,Brilinta Brilique ,Bricanyl Respules ,Andexxa Ondexxya ,Bydureon Byetta ,Sunbelt Securities Inc ,Fairfield Bush ,Exchange Commission ,Jefferies Financial Group ,Nasdaq ,Royal Bank ,Morgan Stanley ,Nemes Rush Group ,Group Wealth Management ,Astrazeneca Company Profile ,Deutsche Bank Aktiengesellschaft ,Astrazeneca ,Parkside Financial Bank ,Free Report ,Wealth Management ,Financial Bank ,Rush Group ,Sunbelt Securities ,Bank Aktiengesellschaft ,Financial Group ,Get Free Report ,Atacand Plus ,Bevespi Aerosphere ,Breztri Aerosphere ,Astrazeneca Daily ,